Comment on Esketamine 5 Years After Approval: Welcome New Data With Continuing Questions
Muhammad Ahmed, Patricia Cabrera, Teodora Doherty, Mai Himedan et autres
0 citationsAmerican Journal of Psychiatry
Teodora Doherty
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
13Publications signalées
356Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on BehaviorTryptophan and brain disordersSuicide and Self-Harm Studies
Publications récentes
Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis
Carla M. Canuso, Cynthia A. Bossie, Dong‐Jing Fu, Rosanne Lane et autres
2 citationsAmerican Journal of Psychiatry
Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis Almost 5 Years After First Approval
Gerard Sanacora, Muhammad Ahmed, Brianne Brown, Patricia Cabrera et autres
31 citationsAmerican Journal of Psychiatry
Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study
Naim Zaki, Li Chen, Rosanne Lane, Teodora Doherty et autres
38 citationsThe International Journal of Neuropsychopharmacology
Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis of Esketamine and Respiratory Depression
Craig Chepke, Richard C. Shelton, Gerard Sanacora, Teodora Doherty et autres
9 citationsThe International Journal of Neuropsychopharmacology
Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone
David M. Kern, Carla M. Canuso, Ella Daly, Jonathan Johnson et autres
37 citationsBrain and Behavior
Author response for "Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone"
David M. Kern, Carla M. Canuso, Ella Daly, Jonathan Johnson et autres
0 citations
Long-Term Safety and Maintenance of Response With Esketamine Nasal Spray in Participants With Treatment-Resistant Depression: Interim Results of the SUSTAIN-3 Study
Naim Zaki, Li Chen, Rosanne Lane, Teodora Doherty et autres
129 citationsNeuropsychopharmacology
Long-term safety and maintenance of response with esketamine nasal spray in treatment-resistant depression – final results of the SUSTAIN-3 study
Allan H. Young, N. Mohd Zaki, N. Chen, R. Lane et autres
1 citationNeuroscience Applied
Comments to Drs. Gastaldon, Raschi, Kane, Barbui, and Schoretsanitis
Teodora Doherty, Ella Daly, Janice Miller, Vanina Popova et autres
5 citationsPsychotherapy and Psychosomatics
Benefit–Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment‐Resistant Depression
Eva G. Katz, David Hough, Teodora Doherty, Rosanne Lane et autres
36 citationsClinical Pharmacology & Therapeutics
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Teodora Doherty, Ewa Wajs, Rama Melkote, Janice Miller et autres
68 citationsCNS Drugs
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.